Aap Implantate AG Reports 2% Revenue Growth in Q3 2026

aap Implantate AG has announced a 2% increase in its revenue for the third quarter of 2026, totaling EUR 3.3 million. This growth comes despite a challenging comparison to a strong prior-year quarter, reflecting gradual improvement throughout the year.

The U.S. segment experienced a 2% rise in local currency, maintaining its status as a significant growth driver for the company. Meanwhile, the EMEA region saw a 3% revenue increase, with particular gains in the Middle East and product-driven growth in Spain and Portugal.

In LATAM, revenues stabilized, matching the previous year's impressive quarter. However, APAC faced a 14% revenue decline compared to 2025's robust growth. Despite these mixed regional performances, aap remains optimistic about future growth in Q4.

Cumulative revenue during the first nine months of 2026 was recorded at EUR 9.3 million, slightly below the previous year's figure. Nonetheless, EBITDA improvements indicate ongoing operational efficiency and cost control.